AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15206991
Drug: Terbogrel 50
RxNorm normalized name: Terbogrel
DrugBank: Terbogrel (DB12204)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbogrel 50 mg, 100 mg, 150 mg
Trial: 15206991
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 330 mg once-a-day
Trial: 11143737
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 550 mg or ibuprofen 400 mg
Trial: 9360028
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day ASA at Time 2 (7h to 9h after awakening)
Trial: 9360028
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day ASA at Time 3 (within 2h of bedtime)
Trial: 9360028
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day ASA at Time 2 (7h to 9h after awakening)
Trial: 9360028
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day ASA for hypertensive patients at Time 2 (7h to 9h after awakening)
Trial: 9360028
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day ASA for hypertensive patients at Time 3 (within 2h of bedtime)
Trial: 3009050
Drug: Abrupt withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt withdrawal of beta-blockers (group 1)
Trial: 3009050
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (group 1)
Trial: 3009050
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of beta-blockade therapy (group 4)
Trial: 25028177
Drug: Antiarrhythmic Drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic Drug Therapy (ADT)
Trial: 11855793
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg daily)
Trial: 9180836
Drug: Ifosfamide 15
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ifosfamide 15 g/m2/cycle
Trial: 9180836
Drug: Ifosfamide 3
RxNorm normalized name: ifosfamide 3000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ifosfamide 3 g/m2 during 5 days
Trial: 1587761
Drug: Twice-a-day radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-day radiation therapy (hyperfractionation) delivering 120 cGy per fraction, two fractions a day for a total of 6000 cGy in 50 fractions over 5 weeks
Trial: 3929934
Drug: Duodenal capsule
RxNorm normalized name: Sus scrofa duodenum preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal capsule biopsy
Trial: 3929934
Drug: Jejunal capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jejunal capsule biopsy
Trial: 31667062
Drug: Saracatinib 125
RxNorm normalized name: Saracatinib
DrugBank: Saracatinib (DB11805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saracatinib 125 mg/day for 28 days
Trial: 27755159
Drug: Peony-Glycyrrhiza Decoction
RxNorm normalized name: GLYCYRRHIZA
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peony-Glycyrrhiza Decoction (PGD) 45 g/d for 16 weeks
Trial: 20542963
Drug: Modified-release (MR)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified-release (MR) prednisone (2-10 mg/day)
Trial: 17054466
Drug: Raloxifene (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (180 mg/day) + Oestradiol (100 microg/24 h for last 10 days)
Trial: 17054466
Drug: Clomiphene (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene (150 mg/day) + Oestradiol (100 microg/24 h for last 10 days)
Trial: 17054466
Drug: Oestradiol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (100 microg/24 h for 30 days) + Raloxifene (180 mg/day for last 10 days)
Trial: 17054466
Drug: Oestradiol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol (100 microg/24 h for 30 days) + Clomiphene (150 mg/day for last 10 days)
Trial: 11937566
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg BIRB 796 BS
Trial: 11937566
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg BIRB 796 BS
Trial: 7933324
Drug: Diphtheria and
RxNorm normalized name: Diphtheria and tetanus vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria and tetanus toxoid vaccine (DT) primed infants given PRP-T
Trial: 7933324
Drug: Diphtheria and
RxNorm normalized name: Diphtheria and tetanus vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria and tetanus toxoid vaccine (DT) primed infants given HbOC
Trial: 29520889
Drug: Artichoke leaf
RxNorm normalized name: artichoke leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artichoke leaf extract (ALE) 600 mg daily
Trial: 28443702
Drug: Turmeric supplementation
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turmeric supplementation (6 capsules daily for 12 weeks, each containing 500 mg turmeric powder)
Trial: 28443702
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 capsules daily for 12 weeks)
Trial: 9764991
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day for 2 weeks (Group 1)
Trial: 9764991
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg twice a week for 2 weeks (Group 2)
Trial: 9764991
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg once a week for 2 weeks (Group 3)
Trial: 9764991
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg once a week for 12 weeks (Group 4)
Trial: 8550361
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan 6 mg (second injection)
Trial: 8550361
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan 6 mg (rescue medication)
Trial: 719892
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg vitamin E daily for two weeks
Trial: 31833004
Drug: Pseudo-laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudo-laser treatment
Trial: 21812357
Drug: Magnesium carbonate
RxNorm normalized name: Magnesium Carbonate
DrugBank: Magnesium carbonate (DB09481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium carbonate 3 x 1 g
Trial: 21812357
Drug: Sevelamer hydrochloride
RxNorm normalized name: Sevelamer Hydrochloride
DrugBank: Sevelamer (DB00658)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevelamer hydrochloride 0.8 g‐‐3 x 2 tabl (3 x 1.6 g)
Trial: 21812357
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 3 x 2 g
Trial: 10965439
Drug: Trimovax vaccine
RxNorm normalized name: rabies virus vaccine wistar strain PM-1503-3M (human), inactivated Injection [Imovax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimovax vaccine
Trial: 9244021
Drug: First arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First arterial sample (discard volume 4.5 ml)
Trial: 9244021
Drug: Second arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second arterial sample (discard volume 16 ml)
Trial: 22575796
Drug: Traditional center-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional center-based exercise therapy approach (TRAD)
Trial: 25894719
Drug: Manual injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual injection
Trial: 13678478
Drug: Clarithromycin extended-release
RxNorm normalized name: Clarithromycin Extended-Release Tablets
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin extended-release (ER) 500 mg once daily for 5 days
Trial: 13678478
Drug: Clarithromycin immediate-release
RxNorm normalized name: clarithromycin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin immediate-release (IR) 250 mg twice daily for 5 days
Trial: 1735395
Drug: Tramadol 15
RxNorm normalized name: traMADol 150 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 15 mg h‐1 infusion (Group I)
Trial: 6336600
Drug: Spironolactone, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone, 400 mg/d
Trial: 6336600
Drug: Chlorthalidone, 100
RxNorm normalized name: Chlorthalidone, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone, 100 mg/d
Trial: 30723231
Drug: Placebos provided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebos provided with a psychological treatment rationale
Trial: 27843307
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation, 3.2 g daily for 6 weeks
Trial: 24621319
Drug: Zonisamide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zonisamide (1 mg/kg/day up-titrated to 8 mg/kg/day, maximum 500 mg/day)
Trial: 17501980
Drug: Nobel Direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nobel Direct and Nobel Perfect one-piece implants (OPIs)
Trial: 17501980
Drug: Two-piece implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-piece implants (TPIs)
Trial: 29581202
Drug: Non-interventional methods
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-interventional methods for assessing COPD treatment effectiveness
Trial: 26562679
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of motivational enhancement and cognitive behavioral therapy
Trial: 26562679
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment plus additional 'check-up' sessions
Trial: 18178097
Drug: Novel agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel agents (thalidomide, lenalidomide, bortezomib, dexamethasone)
Trial: 8790203
Drug: Rhenium-186-etidronate (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhenium-186-etidronate (doses ranging from 1295 MBq to 3515 MBq)
Trial: 6734920
Drug: Dicyclomine (Merbentyl)
RxNorm normalized name: dicyclomine hydrochloride Oral Tablet [Merbentyl]
DrugBank: Dicyclomine (DB00804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dicyclomine (Merbentyl) + Antacid
Trial: 27252426
Drug: ETN reduced-dose
RxNorm normalized name: ETN
DrugBank: Erythrityl tetranitrate (DB01613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETN reduced-dose group
Trial: 21279478
Drug: Mesalamine 800
RxNorm normalized name: mesalamine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine 800 mg b.i.d for 10 days every month
Trial: 21279478
Drug: No 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No 5-ASA medications
Trial: 20709109
Drug: Hydroxyethyl cellulose
RxNorm normalized name: Hydroxyethyl Cellulose
DrugBank: Hydroxyethyl cellulose (DB11602)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl cellulose (HEC) gel
Trial: 20709109
Drug: Methylcellulose (MC)
RxNorm normalized name: Methylcellulose
DrugBank: Methylcellulose (DB11228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcellulose (MC) gel
Trial: 20709109
Drug: Thin gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thin gel layers in Transwell system
Trial: 18004139
Drug: levodopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levodopa (100 mg)
Trial: 20398447
Drug: Collagen injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen injection
Trial: 11203756
Drug: Capsaicin injection
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin injection after tooth grinding (exercise session)
Trial: 11203756
Drug: Capsaicin injection
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin injection without tooth grinding (non-exercise session)
Trial: 8866629
Drug: Pravastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (20 mg) administered in the morning
Trial: 8866629
Drug: Pravastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (20 mg) administered in the evening
Trial: 8866629
Drug: Pravastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (20 mg) administered in the morning or evening
Trial: 6143185
Drug: Gentamicin and
RxNorm normalized name: Gentamicin and prednisolone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin and clindamycin (G/C group)
Trial: 26666457
Drug: Sensorimotor training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensorimotor training (SMT) with 15 minutes added to standard physiotherapy (PT) treatment
Trial: 26666457
Drug: Standard physiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physiotherapy (PT) treatment with 15 minutes of sub-effective low-intensity endurance training
Trial: 23544761
Drug: Adherent metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherent metformin participants
Trial: 17578859
Drug: Intact parathyroid
RxNorm normalized name: Intact parathyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact parathyroid hormone (iPTH) levels measured every 3 months and at relapse
Trial: 17578859
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D deficiency defined as S-25(OH)D < or = 37 nmol/l
Trial: 17578859
Drug: Calcium, phosphate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium, phosphate, magnesium, chloride, alkaline phosphatase, albumin, and thyroid stimulating hormone levels measured
Trial: 10706012
Drug: German patients
RxNorm normalized name: German cockroach allergenic extract
DrugBank: Blatella germanica (DB10418)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: German patients (G-Pat)
Trial: 9366820
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine 250 mg/day for 12 or 24 weeks
Trial: 1383825
Drug: Buprenorphine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (8 mg SL daily)
Trial: 1383825
Drug: Buprenorphine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (8 mg SL every other day)
Trial: 30875527
Drug: ADSTEP (Assistive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADSTEP (Assistive Device Selection, Training and Education Program) - a multicomponent program of walking aid selection, fitting and six weekly progressive task‐oriented walking aid training sessions
Trial: 27146373
Drug: Daily training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily training for 12 weeks in phoneme/grapheme mapping, reading comprehension, and reading speed (Intervention group, n=47)
Trial: 24498399
Drug: LMWF-5A (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWF-5A (4 mL or 10 mL)
Trial: 23300745
Drug: Azacitidine 37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azacitidine 37.5 mg/sqm
Trial: 23300745
Drug: Azacitidine 75
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine 75 mg/sqm
Trial: 23300745
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (7+3 cytarabine plus daunorubicin and intermediate-dose cytarabine)
Trial: 20591173
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen 100 mg
Trial: 20591173
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen 200 mg
Trial: 11940545
Drug: Beta-blocker nebivolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker nebivolol 5 mg daily
Trial: 10633487
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose haloperidol
Trial: 8746104
Drug: Cefatrizine at
RxNorm normalized name: cefatrizine
DrugBank: Cefatrizine (DB13266)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefatrizine at a dose of 1 g/day for 10 days
Trial: 8746104
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil at a dose of 400 mg/day for 10 days
Trial: 2693918
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (50 mg i.m. every 3 or 4 weeks)
Trial: 3124456
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate therapy
Trial: 322696
Drug: Intravenous BCG
RxNorm normalized name: Tice BCG Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous BCG treatment
Trial: 322696
Drug: Chemotherapy only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy only (DNR/ARAC)
Trial: 30802689
Drug: AL 441
RxNorm normalized name: Al
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL 441 mg
Trial: 30802689
Drug: AL 882
RxNorm normalized name: Al
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL 882 mg
Trial: 16422960
Drug: Vardenafil 10
RxNorm normalized name: vardenafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 10 mg or 20 mg
Trial: 17713974
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg (oral administration)
Trial: 15921803
Drug: Carvedilol (non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (non-selective beta-blocker)
Trial: 11684630
Drug: Metoprolol (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (selective beta-blocker)
Trial: 8599282
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 300 mg administered in a 120 min iv infusion
Trial: 2698515
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg Cinoxacin b.i.d. for 5 days
Trial: 30967597
Drug: CYP19A1 low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: CYP19A1 low estrogen alleles rs10046 G and rs4646 A
Trial: 26531075
Drug: Minimal caries
RxNorm normalized name: Tilletia caries
DrugBank: Tilletia caries (DB10705)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal caries removal with both resin‐modified glass ionomer base material and luting cement (MCRB/L)
Trial: 23627832
Drug: DBX (thermogenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBX (thermogenic dietary supplement containing 340 mg of total caffeine plus green tea extract, yerba mate extract, carnitine tartrate)
Trial: 21628014
Drug: MiroCam capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MiroCam capsule
Trial: 16923310
Drug: Glutamine and
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine and antioxidant therapy
Trial: 12505808
Drug: 1% testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% testosterone gel, 10 g/day
Trial: 9856366
Drug: Captopril at
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril at 50 mg twice a day
Trial: 1694945
Drug: Xamoterol 200
RxNorm normalized name: xamoterol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol 200 mg twice daily for 13 weeks
Trial: 1694945
Drug: Placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo twice daily for 13 weeks
Trial: 1694945
Drug: Xamoterol 200
RxNorm normalized name: xamoterol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol 200 mg
Trial: 41475
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg i.v. dose of labetalol
Trial: 41475
Drug: 2.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg/kg i.v. dose of labetalol
Trial: 27997257
Drug: Carbohydrate gel
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate gel
Trial: 22462237
Drug: High-frequency electric
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency electric sparkle and point-injection therapy (HESPT)
Trial: 22462237
Drug: Point-injection therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point-injection therapy
Trial: 11730179
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 110, 220, 330, and 440 microg, twice daily